MEA Pancreatic Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Description

List of Tables

The Middle East and Africa pancreatic cancer diagnostics market is projected to register a substantial CAGR of 5.6% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2023 to 2030.

Market Segmentation:

Middle East and Africa Pancreatic Cancer Diagnostics Market, By Test Type (Imaging Test, Biopsy, Blood Test, Genomic Test, and Others), Cancer Stage (Stage 0, Stage I, Stage II, Stage III and Stage IV), Tumor Type(Exocrine Tumors and Neuroendocrine Tumors), Product (Instrument-Based Products, Platform-Based Products, Kits and Reagents, and Other Consumables), Technology (Fluorescent In Situ Hybridization, Next Generation Sequencing, Fluorimmunoassay, Comparative Genomic Hybridization, Immunohistochemical, and Others), Application(Screening, Diagnostic and Predictive, Prognostic, and Research), End User (Hospitals, Diagnostic Centers, Cancer Research Centers, Academic Institutes, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (South Africa, Saudi Arabia, Bahrain, UAE, Kuwait, Oman, Qatar, Egypt, Israel and the Rest of Middle East and Africa) Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of pancreatic cancer diagnostics market are:

Rise in prevalence and incidence of pancreatic cancer

Increase in awareness about the pancreatic cancer diagnostics

Market Players:

Some of the major players operating in the Middle East and Africa pancreatic cancer diagnostics market are:

Canon Medical Systems ANZ Pty Limited.

Koninklijke Philips N.V.

Siemens Healthcare Private Limited

Abbott

Agilent Technologies, Inc.

Thermo Fisher Scientific

QIAGEN

MP BIOMEDICALS

Laboratory Corporation of America Holdings

Meridian Life Science, Inc.

1 INTRODUCTION 91

1.1 OBJECTIVES OF THE STUDY 91
1.2 MARKET DEFINITION 91
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET 91
1.4 CURRENCY AND PRICING 94
1.5 LIMITATIONS 94
1.6 MARKETS COVERED 94

2 MARKET SEGMENTATION 98

2.1 MARKETS COVERED 98
2.2 GEOGRAPHICAL SCOPE 99
2.3 YEARS CONSIDERED FOR THE STUDY 100
2.4 DBMR TRIPOD DATA VALIDATION MODEL 101
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 104
2.6 MULTIVARIATE MODELLING 105
2.7 MARKET END USER COVERAGE GRID 106
2.8 PRODUCT LIFELINE CURVE 107
2.9 DBMR MARKET POSITION GRID 108
2.10 VENDOR SHARE ANALYSIS 109
2.11 SECONDARY SOURCES 110
2.12 ASSUMPTIONS 110

3 EXECUTIVE SUMMARY 111

4 PREMIUM INSIGHTS 114

4.1 PESTEL ANALYSIS 115
4.2 PORTER'S FIVE FORCES MODEL 116

5 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, INDUSTRY INSIGHTS 117

6 EPIDEMIOLOGY 119

7 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, REGULATIONS 120

8 MARKET OVERVIEW 123

8.1 DRIVERS 125
- 8.1.1 GROW IN PREVALENCE OF PANCREATIC CANCER 125
- 8.1.2 NOVEL TECHNOLOGICAL ADVANCEMENTS IN PANCREATIC DIAGNOSTICS 125
- 8.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 126
- 8.1.4 INCREASE IN AWARENESS REGARDING PANCREATIC CANCER 126
8.2 RESTRAINTS 127
- 8.2.1 STRICT REGULATIONS AND STANDARDS FOR THE APPROVAL AND COMMERCIALIZATION OF PANCREATIC CANCER DIAGNOSTIC PRODUCTS 127
- 8.2.2 LATE DIAGNOSIS AND POOR PROGNOSIS OF PANCREATIC CANCER 127
8.3 OPPORTUNITIES 128
- 8.3.1 INCREASE IN DIAGNOSTIC PRODUCTS FOR PANCREATIC CANCER 128
- 8.3.2 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 129
- 8.3.3 GOVERNMENT INITIATIVES TOWARD PANCREATIC CANCER DIAGNOSTICS 129
8.4 CHALLENGES 130
- 8.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 130
- 8.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 130

9 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE 131

9.1 OVERVIEW 132
9.2 IMAGING TEST 135
- 9.2.1 COMPUTED TOMOGRAPHY (CT) SCAN 136
- 9.2.2 MAGNETIC RESONANCE IMAGING (MRI) 136
  - 9.2.2.1 MR CHOLANGIOPANCREATOGRAPHY 136
  - 9.2.2.2 MR ANGIOGRAPHY (MRA) 137
- 9.2.3 ULTRASOUND 137
  - 9.2.3.1 ABDOMINAL ULTRASOUND 137
  - 9.2.3.2 ENDOSCOPIC ULTRASOUND (EUS) 137
- 9.2.4 CHOLANGIOPANCREATOGRAPHY 137
  - 9.2.4.1 MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY (MRCP) 138
  - 9.2.4.2 ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) 138
  - 9.2.4.3 PRECUTANEOUS TRANSHEPTIC CHOLANGIOPANCREATOGRAPHY (PTC) 138
- 9.2.5 POSITRON EMISSION TOMOHRAPHY (PET) 138
- 9.2.6 OTHERS 138
9.3 BIOPSY 139
- 9.3.1 CT-GUIDED NEEDLE BIOPSY 140
- 9.3.2 FINE NEEDLE ASPIRATION (FNA) 140
- 9.3.3 CORE NEEDLE BIOPSY 140
- 9.3.4 OTHERS 140
9.4 BLOOD TEST 140
- 9.4.1 LIVER FUNCTION TEST 141
- 9.4.2 TUMOR MARKER 141
  - 9.4.2.1 CA 19-9 BIOMARKER TEST 142
  - 9.4.2.2 CARCINOEMBROYNIC ANTIGEN (CEA) TEST 142
  - 9.4.2.3 CA 50 MARKER TEST 142
  - 9.4.2.4 OTHERS 142
- 9.4.3 OTHERS 142
9.5 GENOMIC TEST 143
9.6 OTHERS 144

10 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGES 145

10.1 OVERVIEW 146
10.2 STAGE IV 149
10.3 STAGE III 149
10.4 STAGE II 150
- 10.4.1 STAGE IIA 151
- 10.4.2 STAGE IIB 151
10.5 STAGE I 151
- 10.5.1 STAGE IA 152
- 10.5.2 STAGE IB 152
10.6 STAGE 0 153

11 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TUMOR TYPE 154

11.1 OVERVIEW 155
11.2 EXOCRINE TUMORS 158
- 11.2.1 INSTRUMENT-BASED PRODUCTS 159
- 11.2.2 PLATFORM-BASED PRODUCTS 159
- 11.2.3 KITS AND REAGENTS 159
- 11.2.4 OTHER CONSUMABLES 159
11.3 NEUROENDOCRINE TUMORS 159
- 11.3.1 INSTRUMENT-BASED PRODUCTS 160
- 11.3.2 PLATFORM-BASED PRODUCTS 160
- 11.3.3 KITS AND REAGENTS 161
- 11.3.4 OTHER CONSUMABLES 161

12 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT 162

12.1 OVERVIEW 163
12.2 INSTRUMENT-BASED PRODUCTS 166
- 12.2.1 IMAGING 167
- 12.2.2 BIOPSY 167
12.3 PLATFORM-BASED PRODUCTS 167
- 12.3.1 NEXT-GENERATION SEQUENCING 168
- 12.3.2 MICROARRAYS 168
- 12.3.3 PCR 168
- 12.3.4 OTHERS 169
12.4 KITS AND REAGENTS 169
- 12.4.1 CA19-9 PANCREATIC CANCER TEST KITS 170
  - 12.4.1.1 ELISA TEST KITS 170
  - 12.4.1.2 CASETTE TEST KITS 170
  - 12.4.1.3 OTHERS 170
- 12.4.2 CEA PANCREATIC CANCER TEST KITS 171
  - 12.4.2.1 ELISA TEST KITS 171
  - 12.4.2.2 CASETTE TEST KITS 171
  - 12.4.2.3 OTHERS 171
12.5 OTHER CONSUMABLES 171

13 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY 173

13.1 OVERVIEW 174
13.2 FLUORESCENT IN SITU HYBRIDIZATION 177
13.3 NEXT GENERATION SEQUENCING 178
13.4 FLUORIMMUNOASSAY 179
13.5 COMPARATIVE GENOMIC HYBRIDIZATION 180
13.6 IMMUNOHISTOCHEMICAL 181
13.7 OTHERS 182

14 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY APPLICATION 183

14.1 OVERVIEW 184
14.2 SCREENING 187
- 14.2.1 INSTRUMENT-BASED PRODUCTS 188
- 14.2.2 PLATFORM-BASED PRODUCTS 188
- 14.2.3 KITS AND REAGENTS 188
- 14.2.4 OTHER CONSUMABLES 188
14.3 DIAGNOSTIC AND PREDICTIVE 188
- 14.3.1 INSTRUMENT-BASED PRODUCTS 189
- 14.3.2 PLATFORM-BASED PRODUCTS 189
- 14.3.3 KITS AND REAGENTS 189
- 14.3.4 OTHER CONSUMABLES 189
14.4 PROGNOSTIC 190
- 14.4.1 INSTRUMENT-BASED PRODUCTS 191
- 14.4.2 PLATFORM-BASED PRODUCTS 191
- 14.4.3 KITS AND REAGENTS 191
- 14.4.4 OTHER CONSUMABLES 191
14.5 RESEARCH 191
- 14.5.1 INSTRUMENT-BASED PRODUCTS 192
- 14.5.2 PLATFORM-BASED PRODUCTS 192
- 14.5.3 KITS AND REAGENTS 192
- 14.5.4 OTHER CONSUMABLES 192

15 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY END USER 193

15.1 OVERVIEW 194
15.2 HOSPITALS 197
15.3 DIAGNOSTIC CENTERS 197
15.4 CANCER RESEARCH CENTERS 198
15.5 ACADEMIC INSTITUTES 199
15.6 AMBULATORY SURGICAL CENTERS 200
15.7 OTHERS 201

16 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 202

16.1 OVERVIEW 203
16.2 DIRECT TENDER 206
16.3 RETAIL SALES 207
16.4 OTHERS 208

17 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION 209

17.1 MIDDLE EAST AND AFRICA 210
- 17.1.1 SOUTH AFRICA 225
- 17.1.2 SAUDI ARABIA 234
- 17.1.3 BAHRAIN 243
- 17.1.4 UAE 252
- 17.1.5 EGYPT 261
- 17.1.6 ISRAEL 270
- 17.1.7 KUWAIT 279
- 17.1.8 OMAN 288
- 17.1.9 QATAR 297
- 17.1.10 REST OF MIDDLE EAST AND AFRICA 306

18 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: COMPANY LANDSCAPE 307

18.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 307

19 SWOT ANALYSIS 308

20 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET 309

20.1 CANON MEDICAL SYSTEMS CORPORATION 309
- 20.1.1 COMPANY SNAPSHOT 309
- 20.1.2 REVENUE ANALYSIS 309
- 20.1.3 COMPANY SHARE ANALYSIS 310
- 20.1.4 PRODUCT PORTFOLIO 310
- 20.1.5 RECENT DEVELOPMENT 310
20.2 KONINKLIJKE PHILIPS N.V. 311
- 20.2.1 COMPANY SNAPSHOT 311
- 20.2.2 REVENUE ANALYSIS 311
- 20.2.3 COMPANY SHARE ANALYSIS 312
- 20.2.4 PRODUCT PORTFOLIO 312
- 20.2.5 RECENT DEVELOPMENTS 312
20.3 SIEMENS HEALTHCARE GMBH 314
- 20.3.1 COMPANY SNAPSHOT 314
- 20.3.2 REVENUE ANALYSIS 314
- 20.3.3 COMPANY SHARE ANALYSIS 315
- 20.3.4 PRODUCT PORTFOLIO 315
- 20.3.5 RECENT DEVELOPMENT 316
20.4 GRAIL 317
- 20.4.1 COMPANY PROFILE 317
- 20.4.2 COMPANY SHARE ANALYSIS 317
- 20.4.3 PRODUCT PORTFOLIO 318
- 20.4.4 RECENT DEVELOPMENT 318
20.5 MYRIAD GENETICS, INC. 319
- 20.5.1 COMPANY SNAPSHOT 319
- 20.5.2 REVENUE ANALYSIS 319
- 20.5.3 COMPANY SHARE ANALYSIS 320
- 20.5.4 PRODUCT PORTFOLIO 320
- 20.5.5 RECENT DEVELOPMENT 320
20.6 BD 321
- 20.6.1 COMPANY SNAPSHOT 321
- 20.6.2 REVENUE ANALYSIS 321
- 20.6.3 PRODUCT PORTFOLIO 322
- 20.6.4 RECENT DEVELOPMENT 322
20.7 BODITECH MED INC. 323
- 20.7.1 COMPANY PROFILE 323
- 20.7.2 PRODUCT PORTFOLIO 323
- 20.7.3 RECENT DEVELOPMENT 323
20.8 ABBOTT (2022) 324
- 20.8.1 COMPANY SNAPSHOT 324
- 20.8.2 REVENUE ANALYSIS 324
- 20.8.3 PRODUCT PORTFOLIO 325
- 20.8.4 RECENT DEVELOPMENT 325
20.9 FUJIFILM HOLDINGS AMERICA CORPORATION 326
- 20.9.1 COMPANY SNAPSHOT 326
- 20.9.2 REVENUE ANALYSIS 326
- 20.9.3 PRODUCT PORTFOLIO 327
- 20.9.4 RECENT DEVELOPMENT 327
20.10 ACCUBIOTECH CO., LTD. 328
- 20.10.1 COMPANY PROFILE 328
- 20.10.2 PRODUCT PORTFOLIO 328
- 20.10.3 RECENT DEVELOPMENTS 328
20.11 AGILENT TECHNOLOGIES, INC. 329
- 20.11.1 COMPANY PROFILE 329
- 20.11.2 REVENUE ANALYSIS 329
- 20.11.3 PRODUCT PORTFOLIO 330
- 20.11.4 RECENT DEVELOPMENT 330
20.12 CREATIVE BIOLABS. 331
- 20.12.1 COMPANY PROFILE 331
- 20.12.2 PRODUCT PORTFOLIO 331
- 20.12.3 RECENT DEVELOPMENT 331
20.13 CTK BIOTECH, INC. 332
- 20.13.1 COMPANY PROFILE 332
- 20.13.2 PRODUCT PORTFOLIO 332
- 20.13.3 RECENT DEVELOPMENT 332
20.14 DIASOURCE 333
- 20.14.1 COMPANY SNAPSHOT 333
- 20.14.2 PRODUCT PORTFOLIO 333
- 20.14.3 RECENT DEVELOPMENT 333
20.15 LABORATORY CORPORATION OF AMERICA HOLDINGS 334
- 20.15.1 COMPANY SNAPSHOT 334
- 20.15.2 REVENUE ANALYSIS 334
- 20.15.3 PRODUCT PORTFOLIO 335
- 20.15.4 RECENT DEVELOPMENTS 335

20.16 LEE BIOSCIENCE 336
- 20.16.1 COMPANY SNAPSHOT 336
- 20.16.2 PRODUCT PORTFOLIO 336
- 20.16.3 RECENT DEVELOPMENT 336
20.17 MERIDIAN BIOSCIENCE INC. 337
- 20.17.1 COMPANY PROFILE 337
- 20.17.2 PRODUCT PORTFOLIO 337
- 20.17.3 RECENT DEVELOPMENT 337
20.18 MP BIOMEDICALS. 338
- 20.18.1 COMPANY PROFILE 338
- 20.18.2 PRODUCT PORTFOLIO 338
- 20.18.3 RECENT DEVELOPMENTS 338
20.19 QIAGEN 339
- 20.19.1 COMPANY SNAPSHOT 339
- 20.19.2 REVENUE ANALYSIS 339
- 20.19.3 PRODUCT PORTFOLIO 340
- 20.19.4 RECENT DEVELOPMENT 340
20.20 SETIA SCIENTIFIC SOLUTION 341
- 20.20.1 COMPANY PROFILE 341
- 20.20.2 PRODUCT PORTFOLIO 341
- 20.20.3 RECENT DEVELOPMENTS 341
20.21 THERMO FISHER SCIENTIFIC INC. 342
- 20.21.1 COMPANY SNAPSHOT 342
- 20.21.2 REVENUE ANALYSIS 342
- 20.21.3 PRODUCT PORTFOLIO 343
- 20.21.4 RECENT DEVELOPMENT 343

21 QUESTIONNAIRE 344

22 RELATED REPORTS 348

LIST OF TABLES

TABLE 1 APPROVED DIAGNOSTICS OF PANCREATIC CANCER 71
TABLE 2 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 77
TABLE 3 MIDDLE EAST & AFRICA IMAGING TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 78
TABLE 4 MIDDLE EAST & AFRICA IMAGING TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 79
TABLE 5 MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING (MRI) IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 79
TABLE 6 MIDDLE EAST & AFRICA ULTRASOUND IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 80
TABLE 7 MIDDLE EAST & AFRICA CHOLANGIOPANCREATOGRAPHY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 81
TABLE 8 MIDDLE EAST & AFRICA BIOPSY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 82
TABLE 9 MIDDLE EAST & AFRICA BIOPSY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 83
TABLE 10 MIDDLE EAST & AFRICA BLOOD TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 84
TABLE 11 MIDDLE EAST & AFRICA BLOOD TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 84
TABLE 12 MIDDLE EAST & AFRICA TUMOR MARKER IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 85
TABLE 13 MIDDLE EAST & AFRICA GENOMIC TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 86
TABLE 14 MIDDLE EAST & AFRICA OTHERS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 87
TABLE 15 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 91
TABLE 16 MIDDLE EAST & AFRICA STAGE IV IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 92
TABLE 17 MIDDLE EAST & AFRICA STAGE III IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 93
TABLE 18 MIDDLE EAST & AFRICA STAGE II IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 94
TABLE 19 MIDDLE EAST & AFRICA STAGE II IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 94
TABLE 20 MIDDLE EAST & AFRICA STAGE I IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 21 MIDDLE EAST & AFRICA STAGE I IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 95
TABLE 22 MIDDLE EAST & AFRICA STAGE 0 IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 96
TABLE 23 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TUMOR TYPE, 2021-2030 (USD MILLION) 100
TABLE 24 MIDDLE EAST & AFRICA EXOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 101
TABLE 25 MIDDLE EAST & AFRICA EXOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 102
TABLE 26 MIDDLE EAST & AFRICA NEUROENDOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 103
TABLE 27 MIDDLE EAST & AFRICA NEUROENDOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103
TABLE 28 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 108
TABLE 29 MIDDLE EAST & AFRICA INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 109
TABLE 30 MIDDLE EAST & AFRICA INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 110
TABLE 31 MIDDLE EAST & AFRICA PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 111
TABLE 32 MIDDLE EAST & AFRICA PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111
TABLE 33 MIDDLE EAST & AFRICA KITS AND REAGENTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 112
TABLE 34 MIDDLE EAST & AFRICA KITS AND REAGENTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 113
TABLE 35 MIDDLE EAST & AFRICA CA19-9 PANCREATIC CANCER TEST KITS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 113
TABLE 36 MIDDLE EAST & AFRICA CEA PANCREATIC CANCER TEST KITS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 114
TABLE 37 MIDDLE EAST & AFRICA OTHER CONSUMABLES IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 115
TABLE 38 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 119
TABLE 39 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 120
TABLE 40 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 121
TABLE 41 MIDDLE EAST & AFRICA FLUORIMMUNOASSAY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 122
TABLE 42 MIDDLE EAST & AFRICA COMPARATIVE GENOMIC HYBRIDIZATION IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 123
TABLE 43 MIDDLE EAST & AFRICA IMMUNOHISTOCHEMICAL IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 124
TABLE 44 MIDDLE EAST & AFRICA OTHERS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 125
TABLE 45 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 129
TABLE 46 MIDDLE EAST & AFRICA SCREENING IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 130
TABLE 47 MIDDLE EAST & AFRICA SCREENING IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 130
TABLE 48 MIDDLE EAST & AFRICA DIAGNOSTIC AND PREDICTIVE IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 132
TABLE 49 MIDDLE EAST & AFRICA DIAGNOSTIC AND PREDICTIVE IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 132
TABLE 50 MIDDLE EAST & AFRICA PROGNOSTIC IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 133
TABLE 51 MIDDLE EAST & AFRICA PROGNOSTIC IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 133
TABLE 52 MIDDLE EAST & AFRICA RESEARCH IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 135
TABLE 53 MIDDLE EAST & AFRICA RESEARCH IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 135
TABLE 54 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 139
TABLE 55 MIDDLE EAST & AFRICA HOSPITALS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 140
TABLE 56 MIDDLE EAST & AFRICA DIAGNOSTIC CENTERS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 141
TABLE 57 MIDDLE EAST & AFRICA CANCER RESEARCH CENTERS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 141
TABLE 58 MIDDLE EAST & AFRICA ACADEMIC INSTITUTES IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 142
TABLE 59 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 143
TABLE 60 MIDDLE EAST & AFRICA OTHERS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 144
TABLE 61 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 148
TABLE 62 MIDDLE EAST & AFRICA DIRECT TENDER IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 149
TABLE 63 MIDDLE EAST & AFRICA RETAIL SALES IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 150
TABLE 64 MIDDLE EAST & AFRICA OTHERS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 151
TABLE 65 MIDDLE EAST AND AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 158
TABLE 66 MIDDLE EAST AND AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 158
TABLE 67 MIDDLE EAST AND AFRICA IMAGING TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 159
TABLE 68 MIDDLE EAST AND AFRICA MAGNETIC RESONANCE IMAGING (MRI) IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 159
TABLE 69 MIDDLE EAST AND AFRICA ULTRASOUND IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 159
TABLE 70 MIDDLE EAST AND AFRICA CHOLANGIOPANCREATOGRAPHY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 160
TABLE 71 MIDDLE EAST AND AFRICA BLOOD TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 160
TABLE 72 MIDDLE EAST AND AFRICA TUMOR MARKER IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 160
TABLE 73 MIDDLE EAST AND AFRICA BIOPSY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 161
TABLE 74 MIDDLE EAST AND AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 161
TABLE 75 MIDDLE EAST AND AFRICA STAGE I IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 161
TABLE 76 MIDDLE EAST AND AFRICA STAGE II IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 161
TABLE 77 MIDDLE EAST AND AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TUMOR TYPE, 2021-2030 (USD MILLION) 162
TABLE 78 MIDDLE EAST AND AFRICA EXOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 162
TABLE 79 MIDDLE EAST AND AFRICA NEUROENDOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 162
TABLE 80 MIDDLE EAST AND AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 162
TABLE 81 MIDDLE EAST AND AFRICA INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 163
TABLE 82 MIDDLE EAST AND AFRICA INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (UNITS) 163
TABLE 83 MIDDLE EAST AND AFRICA INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD) 163
TABLE 84 MIDDLE EAST AND AFRICA PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 163
TABLE 85 MIDDLE EAST AND AFRICA PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (UNITS) 163
TABLE 86 MIDDLE EAST AND AFRICA PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD) 164
TABLE 87 MIDDLE EAST AND AFRICA KITS AND REAGENTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164
TABLE 88 MIDDLE EAST AND AFRICA CA19-9 PANCREATIC CANCER TEST KITS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164
TABLE 89 MIDDLE EAST AND AFRICA CEA PANCREATIC CANCER TEST KITS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164
TABLE 90 MIDDLE EAST AND AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 165
TABLE 91 MIDDLE EAST AND AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 165
TABLE 92 MIDDLE EAST AND AFRICA SCREENING IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 165
TABLE 93 MIDDLE EAST AND AFRICA DIAGNOSTIC AND PREDICTIVE IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 166
TABLE 94 MIDDLE EAST AND AFRICA PROGNOSTIC IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 166
TABLE 95 MIDDLE EAST AND AFRICA RESEARCH IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 166
TABLE 96 MIDDLE EAST AND AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 167
TABLE 97 MIDDLE EAST AND AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 167
TABLE 98 SOUTH AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 168
TABLE 99 SOUTH AFRICA IMAGING TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 168
TABLE 100 SOUTH AFRICA MAGNETIC RESONANCE IMAGING (MRI) IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 168
TABLE 101 SOUTH AFRICA ULTRASOUND IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 169
TABLE 102 SOUTH AFRICA CHOLANGIOPANCREATOGRAPHY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 169
TABLE 103 SOUTH AFRICA BLOOD TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 169
TABLE 104 SOUTH AFRICA TUMOR MARKER IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 169
TABLE 105 SOUTH AFRICA BIOPSY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 170
TABLE 106 SOUTH AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 170
TABLE 107 SOUTH AFRICA STAGE I IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 170
TABLE 108 SOUTH AFRICA STAGE II IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 170
TABLE 109 SOUTH AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TUMOR TYPE, 2021-2030 (USD MILLION) 171
TABLE 110 SOUTH AFRICA EXOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 171
TABLE 111 SOUTH AFRICA NEUROENDOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 171
TABLE 112 SOUTH AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 171
TABLE 113 SOUTH AFRICA INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 172
TABLE 114 SOUTH AFRICA INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (UNITS) 172
TABLE 115 SOUTH AFRICA INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD) 172
TABLE 116 SOUTH AFRICA PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 172
TABLE 117 SOUTH AFRICA PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (UNITS) 172
TABLE 118 SOUTH AFRICA PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD) 173
TABLE 119 SOUTH AFRICA KITS AND REAGENTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 173
TABLE 120 SOUTH AFRICA CA19-9 PANCREATIC CANCER TEST KITS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 173
TABLE 121 SOUTH AFRICA CEA PANCREATIC CANCER TEST KITS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 173
TABLE 122 SOUTH AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 174
TABLE 123 SOUTH AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 174
TABLE 124 SOUTH AFRICA SCREENING IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 174
TABLE 125 SOUTH AFRICA DIAGNOSTIC AND PREDICTIVE IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 175
TABLE 126 SOUTH AFRICA PROGNOSTIC IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 175
TABLE 127 SOUTH AFRICA RESEARCH IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 175
TABLE 128 SOUTH AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 176
TABLE 129 SOUTH AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 176
TABLE 130 SAUDI ARABIA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 177
TABLE 131 SAUDI ARABIA IMAGING TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 177
TABLE 132 SAUDI ARABIA MAGNETIC RESONANCE IMAGING (MRI) IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 177

LIST OF FIGURES

FIGURE 1 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: SEGMENTATION 40
FIGURE 2 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 43
FIGURE 3 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 44
FIGURE 4 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS 45
FIGURE 5 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 45
FIGURE 6 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 46
FIGURE 7 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID 48
FIGURE 8 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 50
FIGURE 9 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 51
FIGURE 10 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: SEGMENTATION 55
FIGURE 11 GROWING AWARENESS OF PANCREATIC CANCER AND INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET FROM 2023 TO 2030 56
FIGURE 12 IMAGING TEST SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET IN 2023 & 2030 56
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET 66
FIGURE 14 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 74
FIGURE 15 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 75
FIGURE 16 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 75
FIGURE 17 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 76
FIGURE 18 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2022 88
FIGURE 19 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2023-2030 (USD MILLION) 89
FIGURE 20 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, CAGR (2023-2030) 89
FIGURE 21 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, LIFELINE CURVE 90
FIGURE 22 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY TUMOR TYPE, 2022 97
FIGURE 23 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY TUMOR TYPE, 2023-2030 (USD MILLION) 98
FIGURE 24 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY TUMOR TYPE, CAGR (2023-2030) 98
FIGURE 25 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY TUMOR TYPE, LIFELINE CURVE 99
FIGURE 26 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY PRODUCT, 2022 105
FIGURE 27 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY PRODUCT, 2023-2030 (USD MILLION) 106
FIGURE 28 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY PRODUCT, CAGR (2023-2030) 106
FIGURE 29 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY PRODUCT, LIFELINE CURVE 107
FIGURE 30 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, 2022 116
FIGURE 31 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION) 117
FIGURE 32 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, CAGR (2023-2030) 117
FIGURE 33 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, LIFELINE CURVE 118
FIGURE 34 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY APPLICATION, 2022 126
FIGURE 35 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 127
FIGURE 36 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY APPLICATION, CAGR (2023-2030) 127
FIGURE 37 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE 128
FIGURE 38 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY END USER, 2022 136
FIGURE 39 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 137
FIGURE 40 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 137
FIGURE 41 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 138
FIGURE 42 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022 145
FIGURE 43 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 146
FIGURE 44 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 146
FIGURE 45 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 147
FIGURE 46 MIDDLE EAST AND AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 153
FIGURE 47 MIDDLE EAST AND AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 155
FIGURE 48 MIDDLE EAST AND AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 155
FIGURE 49 MIDDLE EAST AND AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 156
FIGURE 50 MIDDLE EAST AND AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: TEST TYPE (2023-2030) 156
FIGURE 51 MIDDLE EAST & AFRICA PANCREATIC CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 249